Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease

Aziz MD, Shah J, Kapoor U, Dimopoulos CN, Ayuk FA, Hogan WJ, Schreiner E, Choe HK, Chen YB, Hexner EO, Etra A, Merli P, Rösler W, Kitko C, Qayed M, Woelfl M, Mielke S, Wudhikarn K, Nakamura R, Ordemann R, Pulsipher MA, Reshef R, Anand S, Yanik G, Morales G, Kowalyk S, Young R, Kroeger N, Schechter-Finkelstein T, Hartwell M, Gergoudis S, Augustine A, Ozbek U, Levine JE, Ferrara JLM (2018)


Publication Type: Conference contribution

Publication year: 2018

Journal

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Conference Proceedings Title: BLOOD

Event location: San Diego, CA US

DOI: 10.1182/blood-2018-99-111200

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Aziz, M.D., Shah, J., Kapoor, U., Dimopoulos, C.N., Ayuk, F.A., Hogan, W.J.,... Ferrara, J.L.M. (2018). Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Aziz, Mina D., et al. "Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease." Proceedings of the 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA WASHINGTON: AMER SOC HEMATOLOGY, 2018.

BibTeX: Download